Application 761121

Type
BLA
Sponsor
GENENTECH

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001POLIVYPOLATUZUMAB VEDOTIN-PIIQINJECTABLE;INJECTION140MGNoNo
002POLIVYPOLATUZUMAB VEDOTIN-PIIQPOWDER;INTRAVENOUS30MG/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50242-103POLIVYpolatuzumab vedotinGenentech, Inc.BLACurrent
50242-103POLIVYpolatuzumab vedotinGenentech, Inc.BLACurrent
50242-105POLIVYpolatuzumab vedotinGenentech, Inc.BLACurrent
50242-105POLIVYpolatuzumab vedotinGenentech, Inc.BLACurrent
50242-105POLIVYpolatuzumab vedotinGenentech, Inc.BLACurrent
50242-105POLIVYpolatuzumab vedotinGenentech, Inc.BLACurrent
50242-105POLIVYpolatuzumab vedotinGenentech, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85483SUPPL 2026-03-24
85430SUPPL 2026-03-20
77697SUPPL 2024-03-04
74033SUPPL 2023-04-20
74031SUPPL 2023-04-20
65898SUPPL2021-01-12
65896SUPPL2021-01-12
59227ORIG2019-07-03
59226ORIG2019-07-02
58998ORIG2019-06-10